Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths DOI Open Access
Miguel Á. Ortega, Cielo García‐Montero, Oscar Fraile‐Martínez

et al.

Journal of Personalized Medicine, Journal Year: 2022, Volume and Issue: 12(6), P. 995 - 995

Published: June 18, 2022

Over the two years that we have been experiencing Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, our challenges race to develop vaccines and difficulties in fighting against new variants due rapid ability of virus evolve. In this sense, different organizations identified classified emerging, distinguishing between concern (VOC), interest (VOI), or under monitoring (VUM). The following review aims describe latest updates focusing on VOC already de-escalated variants, as well impact these had global situation. Understanding intrinsic properties SARS-CoV-2 its interaction with immune system vaccination is essential make out underlying mechanisms led appearance helping determine next steps for better public management pandemic.

Language: Английский

Regional Association between Mean Air Temperature and Case Numbers of Multiple SARS-CoV-2 Lineages throughout the Pandemic DOI Creative Commons
Camilla Mattiuzzi, Brandon Michael Henry, Giuseppe Lippi

et al.

Viruses, Journal Year: 2022, Volume and Issue: 14(9), P. 1913 - 1913

Published: Aug. 30, 2022

The association between mean air temperature and new SARS-CoV-2 case numbers throughout the ongoing coronavirus disease 2019 (COVID-19) pandemic was investigated to identify whether diverse lineages may exhibit environmental behaviors. number of COVID-19 daily cases in province Verona obtained from Veneto Regional Healthcare Service, whilst during same period retrieved Agency for Ambient Prevention Protection Veneto. A significant inverse correlation found up Omicron BA.1/BA.2 predominance (correlation coefficients -0.79 -0.41). then became positive when BA.4/BA.5 were prevalent (r = 0.32). When median value (and interquartile range; IQR) recorded warmer year (June-July) compared across three years pandemic, a gradual increase could be seen over time, 1 (IQR, 0-2) 2020, 22 11-113) 2021, 890 343-1345) 2022. These results suggest that measures preventing infection should not completely abandoned periods year.

Language: Английский

Citations

12

DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome DOI Creative Commons
Martina Bradić, Sarah Taleb,

Binitha Thomas

et al.

Journal of Translational Medicine, Journal Year: 2022, Volume and Issue: 20(1)

Published: Nov. 12, 2022

COVID-19 infections could be complicated by acute respiratory distress syndrome (ARDS), increasing mortality risk. We sought to assess the methylome of peripheral blood mononuclear cells in with ARDS.We recruited 100 patients ARDS under mechanical ventilation and 33 non-COVID-19 controls between April July 2020. were followed at four time points for 60 days. DNA methylation immune cell populations measured each point. A multivariate cox proportional risk regression analysis was conducted identify predictive signatures according survival.The comparison inclusion revealed presence a 14.4% difference promoter-associated CpGs genes that control immune-related pathways such as interferon-gamma interferon-alpha responses. On day 60, 24% died. The inter-comparison baseline last recorded point both groups or intra-comparison end follow-up every group showed most changes occurred disease progressed, mainly AIM gene, which is associated an intensified response those who recovered. Cox higher "Apoptotic execution Pathway" (ROC1, ZNF789, H1F0) increases over twofold.We observed epigenetic signature ARDS. Further, Hypermethylation apoptotic pathway predicts outcome.IMRPOVIE study, NCT04473131.

Language: Английский

Citations

12

A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern DOI Creative Commons
Michela Murdocca, Isabella Romeo,

Gennaro Citro

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(7), P. 891 - 891

Published: July 4, 2024

Genomic surveillance based on sequencing the entire genetic code of SARS-CoV-2 involves monitoring and studying changes variations in disease-causing organisms such as viruses bacteria. By tracing virus, it is possible to prevent epidemic spread community, ensuring a ‘precision public health’ strategy. A peptide-based design was applied provide an efficacious strategy that able counteract any emerging viral variant concern dynamically promptly affect outcomes pandemic at early stage while waiting for production anti-variant-specific vaccine, which require longer times. The inhibition interaction between receptor-binding domain (RBD) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) one cellular receptors (DPP4) its routinely bind infect human cells intriguing therapeutic approach virus from entering cells. Among other modalities developed this purpose, peptides surely offer unique advantages, including ease synthesis, serum stability, low immunogenicity toxicity, small distribution chain costs. Here, we obtained potent new inhibitor rearrangement previously identified peptide has been rationally designed cell dipeptidyl peptidase 4 sequence, ubiquitous membrane protein known RBD-SPIKE virus. This novel (named DPP4-derived), conceived endogenous “drug”, capable targeting latest tested variants with high affinity, reducing VSV* DG-Fluc pseudovirus Omicron’s infection capacity by up 14%, revealed vitro testing Calu-3 Surface plasmon resonance (SPR) confirmed binding affinity DPP4-derived Omicron RBD.

Language: Английский

Citations

2

COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections DOI Open Access
Camilla Mattiuzzi, Giuseppe Lippi

Journal of Infection, Journal Year: 2022, Volume and Issue: 84(5), P. 722 - 746

Published: Jan. 31, 2022

Language: Английский

Citations

11

Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths DOI Open Access
Miguel Á. Ortega, Cielo García‐Montero, Oscar Fraile‐Martínez

et al.

Journal of Personalized Medicine, Journal Year: 2022, Volume and Issue: 12(6), P. 995 - 995

Published: June 18, 2022

Over the two years that we have been experiencing Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, our challenges race to develop vaccines and difficulties in fighting against new variants due rapid ability of virus evolve. In this sense, different organizations identified classified emerging, distinguishing between concern (VOC), interest (VOI), or under monitoring (VUM). The following review aims describe latest updates focusing on VOC already de-escalated variants, as well impact these had global situation. Understanding intrinsic properties SARS-CoV-2 its interaction with immune system vaccination is essential make out underlying mechanisms led appearance helping determine next steps for better public management pandemic.

Language: Английский

Citations

11